Medicine

Opportunities and also challenges for patient-reported end result examination in multimorbidity study and method

.Completing rate of interests.S.E.H. gets financing from the National Principle of Wellness and Care...

Hibernation scientific research used to treat obesity as well as modify rate of metabolism

.Nature Medicine, Posted online: 04 September 2024 doi:10.1038/ s41591-024-03226-wBy recognizing the...

CAR- T as well as cell gene treatments are too expensive

.Nature Medicine, Released online: 04 September 2024 doi:10.1038/ s41591-024-03231-zPoint-of-care pr...

The WHO genomics plan of work with fair application of individual genomics for worldwide wellness

.The magazine of the initial draft of the individual genome series in 20011 was observed by the dawn...

A time-stratified, case\u00e2 $ \"crossover research study of heat direct exposure and also perinatal death from 16 medical facilities in sub-Saharan Africa

.Amongst 138,015 hospital-based singleton childbirths in 4 sub-Saharan African countries, our team n...

Advancing worldwide antibiotic study, growth as well as accessibility #.\n\nMurray, C. J. L. et al. Worldwide worry of bacterial antimicrobial resistance in 2019: a methodical review. Lancet 399, 629\u00e2 $ \"655 (2022 ). AMR Frontrunnerses. In the direction of certain commitments and action in the reaction to antimicrobial resistance. International Leaders Team on Antimicrobial Protection https:\/\/www.amrleaders.org\/resources\/m\/item\/glg-report (4 April 2024). Planet Wellness Association. That releases listing of germs for which brand new prescription antibiotics are actually quickly needed. World Health Organization https:\/\/www.who.int\/news\/item\/27-02-2017-who-publishes-list-of-bacteria-for-which-new-antibiotics-are-urgently-needed (27 February 2017). Globe Health And Wellness Institution. WHO microbial top priority pathogens checklist, 2024: bacterial pathogens of public health relevance to lead research, advancement and also approaches to stop as well as manage antimicrobial protection. Globe Health and wellness Association https:\/\/www.who.int\/publications\/i\/item\/9789240093461 (17 May 2024). Silver, L. L. A Gestalt approach to Gram-negative access. Bioorg. Med. Chem. 24, 6379\u00e2 $ \"6389 (2016 ). Article\u00c2.\nCAS\u00c2.\nPubMed\u00c2.\n\nGoogle.com Scholar\u00c2.\nSundqvist, M. Reversibility of antibiotic protection. Ups. J. Med. Sci. 119, 142\u00e2 $ \"148 (2014 ).\nGoogle Scholar\u00c2.\nPlanet Health And Wellness Association. 2023 anti-bacterial representatives in scientific and preclinical advancement: an outline as well as evaluation. World Health Organization https:\/\/www.who.int\/publications\/i\/item\/9789240094000 (14 June 2024). O' Neill, J. et cetera. AMR Evaluation. May 19, 2016 \u00e2 $\" Addressing drug-resistant diseases internationally: ultimate record and referrals. Evaluation on Antimicrobial Protection https:\/\/amr-review.org\/Publications.html (19 May 2016). Drive-AB Range. DRIVE-AB results: records and also rundown. Drive AB https:\/\/drive-ab.eu\/drive-ab-outputs\/drive-ab-reports\/ (2016 ). Stern, S. et cetera. Appearing the wall: an ask for concurrent action on prescription antibiotics research and development. Boston Consulting Group https:\/\/www.bundesgesundheitsministerium.de\/fileadmin\/Dateien\/5_Publikationen\/Gesundheit\/Berichte\/GUARD_Follow_Up_Report_Full_Report_final.pdf (February, 2017). Anderson, M., Panteli, D. &amp Mossialos, E. Policy Quick 51: Just how can the EU support maintainable development as well as access to effective anti-biotics? plan options for existing as well as brand-new medications. European Observatory on Wellness Equipments as well as Policies https:\/\/eurohealthobservatory.who.int\/publications\/i\/how-can-the-eu-support-sustainable-innovation-and-access-to-effective-antibiotics-policy-options-for-existing-and-new-medicines (21 June 2023). Turnidge, J. &amp Christiansen, K. Prescription antibiotic use and resistance\u00e2 $\" proving the apparent. Lancet 365, 548\u00e2 $ \"549 (2005 ). Article\u00c2.\nPubMed\u00c2.\n\nGoogle Scholar\u00c2.\nGlobe Health And Wellness Company. 2021 Conscious classification. WHO gain access to, view, book, distinction of antibiotics for assessment and also monitoring of making use of. Globe Wellness Institution https:\/\/www.who.int\/publications\/i\/item\/2021-aware-classification (30 September 2021). International Centre for Health Condition Deterrence and also Control. Antimicrobial protection aim ats: exactly how can our experts reach them by 2030? ECDC https:\/\/www.ecdc.europa.eu\/sites\/default\/files\/documents\/amr-brief-eaad-2023-update.pdf (2023 ). World Health And Wellness Company. Absence of advancement readied to weaken antibiotic efficiency and health and wellness gains. Globe Health and wellness Company https:\/\/www.who.int\/news\/item\/22-06-2022-22-06-2022-lack-of-innovation-set-to-undermine-antibiotic-performance-and-health-gains (22 June 2022). Magnano San, L. R. et cetera. How antimicrobial protection is actually linked to temperature improvement: a guide of pair of entwined international problems. Int. J. Environ. Res. Public Health twenty, 1681 (2023 ). Article\u00c2.\n\nGoogle Scholar\u00c2.\nDolecek, C., Shakoor, S., Basnyat, B., Okwor, T. &amp Sartorius, B. Drug-resistant bacterial contaminations: our experts need urgent activity as well as assets that pay attention to the weakest web link. PLoS Biol. Twenty, e3001903 (2022 ). Article\u00c2.\nCAS\u00c2.\nPubMed\u00c2.\nPubMed Central\u00c2.\n\nGoogle.com Scholar\u00c2.\nWorld Health And Wellness Organization. Booster shot coverage. Globe Health Company https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/immunization-coverage (15 July 2024). Chimhini, G., Magwenzi, M. &amp Fitzgerald, F. C. Contamination deterrence and management in low-resource setups: the necessity for the local area, the contextual and the pragmatic. Contaminate. Prev. Pract. 4, 100135 (2022 ). Article\u00c2.\nCAS\u00c2.\nPubMed\u00c2.\n\nGoogle.com Scholar\u00c2.\nNour, S., Stokle, E., Ashiru-Oredope, D. &amp Wesangulae, E. Problems of carrying out antimicrobial stewardship devices in reduced to center income countries (LMICs). Affect. Prev. Pract. 5, 100315 (2023 ). Article\u00c2.\n\nGoogle.com Scholar\u00c2.\nAminov, R. A brief background of the antibiotic era: courses knew as well as challenges for the future. Face. Microbiol. 1, 134 (2010 ). Article\u00c2.\nPubMed\u00c2.\nPubMed Central\u00c2.\n\nGoogle Scholar\u00c2.\nOutterson, K. et al. Person get access to in 14 high-income countries to brand-new antibacterials authorized due to the United States Food and Drug Administration, European Medicines Agency, Japanese Pharmaceuticals as well as Medical Equipment Agency, or Health And Wellness Canada, 2010\u00e2 $ \"2020. Clin. Affect. Dis. 74, 1183\u00e2 $ \"1190 (2022 ). Article\u00c2.\nPubMed\u00c2.\n\nGoogle.com Scholar\u00c2.\nPlanet Health And Wellness Institution. 2021 anti-bacterial brokers in clinical and preclinical development: a guide and study. World Health and wellness Institution https:\/\/www.who.int\/publications\/i\/item\/9789240047655 (27 May 2022). Prescription antibiotics: the business economics have to sustain the science. Attribute 625, 7 (2024 ). Thomas, D. &amp Wessel, C. The state of development in anti-bacterial therapies. Biotechnology Development Institution https:\/\/www.bio.org\/sites\/default\/files\/2022-02\/The-State-of-Innovation-in-Antibacterial-Therapeutics.pdf (February, 2022). Strich, J. et cetera. Analyzing specialist use of next-generation antibiotics against resisting Gram-negative contaminations in U.S. medical facilities: a retrospective pal study. Ann. Intern. Med. 177, 559\u00e2 $ \"572 (2024 ). Article\u00c2.\nPubMed\u00c2.\n\nGoogle.com Scholar\u00c2.\nThomas, D. &amp Wessel, C. The state of technology in anti-bacterial therapeutics. Medical Technology Association https:\/\/www.bio.org\/sites\/default\/files\/2022-04\/BIO-Antibacterial-Report-2022.pdf (February 2022). Renwick, M. J., Brogan, D. M. &amp Mossialos, E. A systematic review as well as essential analysis of incentive tactics for discovery and also development of novel antibiotics. J. Antibiot. 69, 73\u00e2 $ \"88 (2016 ). Article\u00c2.\nCAS\u00c2.\n\nGoogle Scholar\u00c2.\nHealth Urgent Preparedness as well as Action Authority. Trial and error of health care countermeasures. International Payment https:\/\/health.ec.europa.eu\/health-emergency-preparedness-and-response-hera\/preparedness\/research-and-development-medical-countermeasures_en (2024 ). European Percentage. Pre-draft proposal for an European alliance under Perspective Europe One Wellness Antimicrobial Resistance. European Payment https:\/\/research-and-innovation.ec.europa.eu\/system\/files\/2022-02\/ec_rtd_he-partnerships-onehealth-amr.pdf (9 February 2022). International Antibiotic Experimentation Alliance. Entasis Therapeutics as well as the Worldwide Prescription Antibiotic Analysis &amp Advancement Collaboration to create a brand new procedure for gonorrhea. GARDP https:\/\/gardp.org\/entasis-therapeutics-and-the-global-antibiotic-research-development-partnership-to-develop-a-new-treatment-for-gonorrhea\/ (6 July 2017). Atal, I., Trinquart, L., Porcher, R. &amp Ravaud, P. Differential globalization of field- and non-industry-sponsored medical tests. PLoS ONE 10, e0145122 (2015 ). Article\u00c2.\nPubMed\u00c2.\nPubMed Central\u00c2.\n\nGoogle Scholar\u00c2.\nWorld Health And Wellness Association. Amount of clinical test signs up by place, ailment, phase of advancement, grow older as well as sex of test attendees (1999\u00e2 $ \"2022). Planet Health Institution https:\/\/www.who.int\/observatories\/global-observatory-on-health-research-and-development\/monitoring\/number-of-trial-registrations-by-year-location-disease-and-phase-of-development (February 2023). International Prescription Antibiotic R &amp D Alliance. NeoSept1: a study to find out the position of existing and also brand new antibiotics combos to treat newborns that reside in health center with intense sepsis. ISRCTN windows registry https:\/\/www.isrctn.com\/ISRCTN48721236 (17 January 2022). Public Health Agency of Canada. Authorities of Canada creates essential assets to eliminate antimicrobial protection (AMR), Government of Canada https:\/\/www.canada.ca\/en\/public-health\/news\/2023\/05\/government-of-canada-makes-important-investment-to-fight-antimicrobial-resistance-amr.html (11 May 2023). International Anti-biotic Trial And Error Partnership. Asia government financing supports GARDP\u00e2 $ s initiatives to respond to antibiotic protection. GARDP https:\/\/gardp.org\/japan-government-funding-supports-gardps-efforts-to-counter-antibiotic-resistance\/ (19 October 2023). Novo Nordisk Base. Novo Nordisk Foundation companions along with CARB-X to overcome drug-resistant contaminations. novo nordisk base https:\/\/novonordiskfonden.dk\/en\/news\/novo-nordisk-foundation-partners-with-carb-x-to-fight-drug-resistant-infections\/ (9 January 2024). European Commission: European Health And Wellness as well as Digital Exec Firm. Study on delivering AMR clinical countermeasures to the market. Publications Workplace of the European Union https:\/\/op.europa.eu\/en\/publication-detail\/-\/publication\/51b2c82c-c21b-11ed-8912-01aa75ed71a1\/language-en (2023 ). Outterson, K. Approximating the proper size of worldwide pull incentives for anti-bacterial medicines. Health Aff. 40, 1758\u00e2 $ \"1765 (2021 ). Article\u00c2.\n\nGoogle.com Scholar\u00c2.\nEvans, E. J., Meyer, A. &amp Conti, R. M. Dimension a market entrance perks for the development of brand-new antibiotics. Harvard Kennedy School https:\/\/www.hks.harvard.edu\/sites\/default\/files\/centers\/mrcbg\/Final_AWP_232.pdf (May 2024). Morel, C. M. et al. Industry motivations as well as antibiotic resistance: an overview to the antibiotic sensitivity perk. J. Antibiot. 73, 421\u00e2 $ \"428 (2020 ). CAS\u00c2.\n\nGoogle.com Scholar\u00c2.\nBonnifield, R. &amp Towse, A. An eager USG advanced commitment for subscription-based buying of unfamiliar antimicrobials and also its expected return on investment. Facility for Global Growth https:\/\/www.cgdev.org\/publication\/ambitious-usg-advanced-commitment-subscription-based-purchasing-novel-antimicrobials (15 November 2022). Towse, A. &amp Silverman Bonnifield, R. G7 assets in new anti-biotics would certainly settle \u00e2 $\" for every person. Office of Health Economics https:\/\/www.ohe.org\/insight\/g7-investments-in-new-antibiotics-would-pay-off-for-everyone\/ (9 December 2022). NHS England. NHS improves war against deadly contaminations following productive world-first fly. NHS England https:\/\/www.england.nhs.uk\/2023\/07\/nhs-steps-up-battle-against-life-threatening-infections-following-successful-world-first-pilot\/ (11 July 2023). US Congress. S. 1355 \u00e2 $\" PASTEUR Action of 2023. congress.gov www.congress.gov\/bill\/118th-congress\/senate-bill\/1355#:~:text=This%20bill%20authorizes%20the%20Department,and%20contains%20other%20related%20provisions (27 April 2023). European Commission. Reform of the EU pharmaceutical legalisation. European Compensation https:\/\/health.ec.europa.eu\/medicinal-products\/pharmaceutical-strategy-europe\/reform-eu-pharmaceutical-legislation_en (26 April 2023). Gotham, D. et cetera. Repayment versions to attack market breakdowns for antimicrobials: techniques consumed France, Germany, Sweden, the UK, as well as the United States. Health Plan 125, 296\u00e2 $ \"306 (2020 ). Article\u00c2.\nPubMed\u00c2.\n\nGoogle Scholar\u00c2.\nInternational Alliance of Pharmaceutical Manufacturers and also Associations. From protection to resilience: what could the future antibiotic pipe resemble? IFMPA https:\/\/www.ifpma.org\/publications\/from-resistance-to-resilience-what-could-the-future-antibiotic-pipeline-look-like\/ (14 May 2024). International AMR R&ampD Hub &amp Globe Health Organization. Incentivising the development of new anti-bacterial treatments: 2023 report card by the Worldwide AMR R&ampD Hub and That. Global AMR R&ampD Hub https:\/\/globalamrhub.org\/publications\/incentivising-the-development-of-new-antibacterial-treatments-2023\/ (2023 ). Glover, R. E., Singer, A., Roberts, A. P. &amp Kirchhelle, C. Why is actually the UK membership version for antibiotics considered prosperous? Lancet Microorganism 4, e852\u00e2 $ \"e853 (2023 ). Article\u00c2.\nPubMed\u00c2.\n\nGoogle Scholar\u00c2.\nNon-paper \u00e2 $\" novel stimulations for the progression as well as going on the market of antimicrobials. Politician https:\/\/www.politico.eu\/wp-content\/uploads\/2022\/12\/01\/Non-paper-Transferable-exclusivity-voucher-for-AMR-2.pdf (2022 ). Liu, L. et cetera. Global, regional, and also national causes of kid mortality in 2000\u00e2 $ \"13, with estimates to update post-2015 top priorities: an updated step-by-step evaluation. Lancet 385, 430\u00e2 $ \"440 (2015 ). Article\u00c2.\nPubMed\u00c2.\n\nGoogle Scholar\u00c2.\nQuadri, F. et cetera. Antibacterial medicine deficiencies coming from 2001 to 2013: effects for scientific application. Clin. Contaminate. Dis. 60, 1737\u00e2 $ \"1742 (2015 ). Article\u00c2.\nPubMed\u00c2.\n\nGoogle.com Scholar\u00c2.\nBenhabib, A. et al. The French coverage device for medication lacks: summary and also patterns from 2012 to 2018: an empirical retrospective research study. BMJ Open 10, e034033 (2020 ). Article\u00c2.\nPubMed\u00c2.\nPubMed Central\u00c2.\n\nGoogle.com Scholar\u00c2.\nKlein, E. Y. et cetera. Evaluation of that antibiotic consumption and get access to targets in 76 nations, 2000\u00e2 $ \"15: an analysis of pharmaceutical sales information. Lancet Infect. Dis. 21, 107\u00e2 $ \"115 (2021 ). Article\u00c2.\nPubMed\u00c2.\n\nGoogle Scholar\u00c2.\nPyzik, O. Z. &amp Abubakar, I. Dealing with the fakes: taking on substandard as well as falsified medications. Nat. Rev. Dis. Primers 8, 55 (2022 ). Hayhoe, B., Greenfield, G. &amp Majeed, A. Is it acquiring simpler to obtain prescription antibiotics in the UK? Br. J. Gen. Pract. 69, 54\u00e2 $ \"55 (2019 ). Article\u00c2.\nPubMed\u00c2.\nPubMed Central\u00c2.\n\nGoogle.com Scholar\u00c2.\nBlack Society for Laboratory Medicine. Plan short and infographics on antimicrobial resistance (AMR) in Africa. ASLM https:\/\/aslm.org\/resource\/policy-brief-and-infographics-on-antimicrobial-resistance-amr-in-africa\/ (14 September 2022). Kanu, J. S. et al. National antibiotic intake for individual use in Sierra Leone (2017\u00e2 $ \"2019): a cross-sectional research. Trop. Medication. Contaminate. Dis. 6, 77 (2021 ). Article\u00c2.\nPubMed\u00c2.\nPubMed Central\u00c2.\n\nGoogle Scholar\u00c2.\nNamugambe, J. S. et cetera. National antimicrobial usage: evaluation of core stockrooms supplies to in-patient care health establishments from 2017 to 2019 in Uganda. Trop. Medication. Contaminate. Dis. 6, 83 (2021 ).\nGoogle.com Scholar\u00c2.\nRobertson, J. et cetera. Varieties in the consumption of antimicrobial medicines in the European location, 2014\u00e2 $ \"2018: lookings for as well as ramifications from ESAC-Net as well as That Europe. Front end. Pharmacol. 12, 639207 (2021 ). Article\u00c2.\nCAS\u00c2.\nPubMed\u00c2.\nPubMed Central\u00c2.\n\nGoogle.com Scholar\u00c2.\nShukar, S. et cetera. Medicine deficiency: triggers, influence, and relief approaches. Face. Pharmacol. 12, 693426 (2021 ). Article\u00c2.\nCAS\u00c2.\nPubMed\u00c2.\nPubMed Central\u00c2.\n\nGoogle.com Scholar\u00c2.\nOutterson, K., Orubu, E. S. F., Rex, J., \u00c3 ... rdal, C. &amp Zaman, M. H. Client get access to in 14 high-income nations to brand-new antibacterials accepted by the US Fda, European Medicines Firm, Japanese Pharmaceuticals and Medical Tools Firm, or Health And Wellness Canada, 2010\u00e2 $ \"2020. Clin. Contaminate. Dis. 74, 1183\u00e2 $ \"1190 (2021 ). Article\u00c2.\nPubMed Central\u00c2.\n\nGoogle Scholar\u00c2.\nPulcini, C. et cetera. Wasted anti-biotics: a follow-up supply research in Europe, the USA, Canada as well as Australia. Int. J. Antimicrob. Agents 49, 98\u00e2 $ \"101 (2017 ). Article\u00c2.\nCAS\u00c2.\nPubMed\u00c2.\n\nGoogle Scholar\u00c2.\nRottingen, J. A. &amp Farrar, J. Targeted health innovation for worldwide health and wellness. Br. Med. J. 366, 15601 (2019 ).\nGoogle Scholar\u00c2.\nAMR Business Alliance. The 2023 AMR Sector Collaboration progress survey: production as well as the setting. amr Field Partnership https:\/\/www.amrindustryalliance.org\/wp-content\/uploads\/2023\/12\/AMRIA_Manufacturing-and-the-environment-FINAL.pdf (2023 ). Munoz, V., Visentin, F., Invasion, D. &amp Gaule, P. Can clinical items be actually developed on a non-profit basis? Exploring product growth alliances for ignored ailments. Sci. Public Policy 42, 315\u00e2 $ \"338 (2015 ). Article\u00c2.\n\nGoogle.com Scholar\u00c2.\nSwaminathan, S. et al. Reboot biomedical R&ampD in the worldwide social passion. Attribute 602, 207\u00e2 $ \"210 (2022 ). Article\u00c2.\nCAS\u00c2.\nPubMed\u00c2.\n\nGoogle Scholar\u00c2.\nAfrica Centres for Health Condition Management and Deterrence. Africa CDC heads daring relocate to safeguard Africa\u00e2 $ s wellness future by making a fifty billion buck health care market. AfricaCDC https:\/\/africacdc.org\/news-item\/africa-cdc-spearheads-bold-move-to-secure-africas-health-future-by-creating-a-50-billion-dollar-medical-market\/ (19 February 2024). Gore, C., Morin, S., R\u00c3 \u00b8 ttingen, J. A. &amp Kieny, M. P. Negotiating public-health trademark licensing deals to improve access to health and wellness technologies: an insider\u00e2 $ s tale. BMJ Glob. Health and wellness 8, e012964 (2023 ). Article\u00c2.\nPubMed\u00c2.\nPubMed Central\u00c2.\n\nGoogle Scholar\u00c2.\nSuleman, F., Low, M., Moon, S. &amp Morgan, S. G. New business styles for r &amp d along with price requirements are required to attain decent rates of medicines. Br. Med. J. 368, l4408 (2020 ). Article\u00c2.\n\nGoogle Scholar\u00c2.\nCombating Antibiotic-Resistant Micro-organisms Biopharmaceutical Accelerator. Stewardship and gain access to. CARB-X https:\/\/carb-x.org\/about\/stewardship-and-access\/ (2024 ). Worldwide Anti-biotic Trial And Error Relationship. Shinogi, GARDP and also CHAI introduce spots permit as well as partnership contracts to handle bacterial diseases next to increasing accessibility to cefiderocol in 135 countries. GARDP https:\/\/gardp.org\/shionogi-gardp-and-chai-announce-landmark-license-and-collaboration-agreements-to-treat-bacterial-infections-by-expanding-access-to-cefiderocol-in-135-countries\/ (15 June 2022). AMR Field Partnership. Leaving the lab: tracking the decline in AMR R&ampD specialists. amr Field Alliance https:\/\/www.amrindustryalliance.org\/wp-content\/uploads\/2023\/02\/Leaving-the-Lab_final-1.pdf (February, 2024). G7 Health Ministers. G7 Health Ministers\u00e2 $ Communiqu\u00c3 \u00a9. G7 Germany www.g7germany.de\/resource\/blob\/974430\/2042058\/5651daa321517b089cdccfaffd1e37a1\/2022-05-20-g7-health-ministers-communique-data.pdf (20 May 2022). G20. G20 call to activity on antimicrobial protection. G7G20 Files Data source https:\/\/g7g20-documents.org\/database\/document\/2022-g20-indonesia-sherpa-track-health-ministers-ministers-annex-g20-call-to-action-on-antimicrobial-resistance (28 Oct 2022). Global Union on Getting Older &amp Infectious Health Conditions Culture of The United States. 2024 AMR readiness mark report card. Assessing authorities action on AMR policy. Worldwide Union on Aging https:\/\/globalcoalitiononaging.com\/wp-content\/uploads\/2024\/01\/2024-AMR-Index-Progress-Report.pdf (2024 ). Food and Horticulture Institution of the United Nations, United Nations Atmosphere Program, Globe Health Organization &amp. Globe Company for Animal Health. Worldwide data source for tracking antimicrobial protection (AMR): nation self-assessment survey (TrACSS). WHO https:\/\/amrcountryprogress.org\/

/map-viewindicator2.3 (2023 ). Vehicle Katwyk, S. R. &amp Outterson K. Intro: AMR belongs in the glo...

Integrating liver endpoints in medical tests of cardio as well as renal ailment

.Nature Medicine, Posted online: 03 September 2024 doi:10.1038/ s41591-024-03223-zThis Viewpoint ask...

FALSE:: MISTAKE: UNSUPPORTED ENCODING...

Artificial cleverness helped screening for cardiomyopathies in an obstetric population: a pragmatic randomized clinical test

.Test design and also oversightThe Assessment for PEripartum Cardiomyopathies along with Expert Syst...

Sustained HIV remission after allogeneic hematopoietic stalk tissue hair transplant with wild-type CCR5 benefactor cells

.Attribute Medication, Published online: 02 September 2024 doi:10.1038/ s41591-024-03277-zHIV remiss...